home.social

#scformulation — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #scformulation, aggregated by home.social.

  1. Korea @[email protected] ·

    Keytruda Patent Expires in Two Years; Samsung Bioepis Targets 47 Trillion Won Market with In-House Technology

    As Samsung Bioepis secures subcutaneous injection (SC) formulation technology on its own, the global biosimilar competition is expanding…
    #EuropeSays #Korea #KR #SamsungBiologics #Alteogen #biosimilar #Celltrion #Keytruda #PH20technology #Samsung #SamsungBioepis #SCformulation
    europesays.com/korea/84352/

    #scformulation #samsungbioepis #samsung #ph20technology #keytruda #celltrion